Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)
Clinical trial NCT04803929 · UNKNOWN
Trial details
- NCT number
- NCT04803929
- Sponsor
- Carbiogene Therapeutics Co. Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-03
- Primary completion
- 2024-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.